MedTrace Logo

Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients

NCT07090005 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 184

Last updated 2026-01-21

No results posted yet for this study

Summary

evaluation of the EndoZip system procedure compared to the Apollo ESG procedure in obese patients.

Conditions

Interventions

DEVICE

EndoZip System

The EndoZip System is a single-use automated suturing device, designed to create multiple internal gastric segmentations in the stomach using an endoscopic approach.

DEVICE

OverStitch Endoscopic Suturing System (ESG)

The OverStitch ESG is suturing device, designed to create manual suturing in the stomach using an endoscopic approach.

Sponsors & Collaborators

  • Nitinotes Surgical Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-14
Primary Completion
2027-06-01
Completion
2027-07-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07090005 on ClinicalTrials.gov